Wire · operational-macro
Opinion: Emerging biotech hubs step up as innovation economics evolve
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 16 November 2026 · Fusion42 review
Emerging biotech hubs like India and China are evolving from low-cost manufacturing sites to centres of innovation by leveraging lower development costs, strong scientific talent, and improving regulatory frameworks to develop affordable breakthrough therapies. These hubs aim to address the economic challenges of sustainable drug development for large patient populations and are supported by significant government R&D initiatives.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
Biotech founders should engage with emerging hubs like India to tap lower development costs and evolving regulatory pathways now opening new routes for affordable breakthrough therapies. This evolution in innovation economics shifts the balance away from traditional high-cost Western models, creating fresh entry points and competitive landscapes.
◆ Coverage
1 source · 16 Nov 2026
◆ Related on Wire
◆ Topics